APUS vs EA · $2.4M cap vs P/E 37, rev $7.46B
Apimeds Pharmaceuticals US, Inc. (APUS) versus Electronic Arts Inc (EA) — a side-by-side from cached financials, not a winner call.
Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.
Electronic Arts Inc (EA) is a electronic gaming & multimedia company listed on US. It is led by Andrew Wilson.
APUS does not have a complete income-statement cache yet.
Latest reported EA revenue for 2025-03-31 was $7.46B. Net income was $1.12B. EA currently screens at market cap $39.46B and trailing P/E 36.9.
APUS currently screens at market cap $2.4M. EA currently screens at market cap $39.46B and trailing P/E 36.9.
Not investment advice. Open the APUS and EA stock pages for the full models.
Not investment advice.